Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery

European Journal of Clinical Pharmacology

Volumn 54, Issue 1, 1998, Pages 21-25

  Abe, K ^a   Sakakibara, T ^b   Miyamoto, Y ^c   Ohnishi, K ^c  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c Sakurabashi Watanabe Hospital   (Japan)

Author keywords

Prostaglandin E1; Pulmonary Hypertension

Indexed keywords

PROSTAGLANDIN E1; PROTAMINE; HEPARIN ANTAGONIST;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; DRUG EFFECT; DRUG SCREENING; FEMALE; HEART OUTPUT; HEART SURGERY; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC VASCULAR RESISTANCE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY; TIME;

AGED; ALPROSTADIL; CARDIOPULMONARY BYPASS; FEMALE; HEMODYNAMIC PROCESSES; HEPARIN ANTAGONISTS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROTAMINES; TIME FACTORS;

EID: 0031596985     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050414     Document Type: Article

References (15)

1. Packer M (1985) Vasodilator therapy for primary pulmonary hypertension. Ann Intern Med 103: 258 270
2. Gray RJR (1988) Posteardiac surgical hypertension. J Cardiothorac Anesth 2: 678 682
3. Kaplan JA, Finlayson DC, Woodward S (1980) Vasodilator therapy after cardiac surgery: a review of the efficacy and toxicity of nitroglycerin and nitroprusside. Can Anaesth Soc J 27: 254-258
4. 1. Ann Thorac Surg 50: 303 305
5. Takenoshita M, Sugiyama M, Okuno Y, Inagaki Y, Yoshiya I, Shimazaki Y (1996) Anaphylactoid reaction to protamine confirmed by plasma tryptase in a diabetic patient during open heart surgery. Anesthesiology 84: 233-235
6. Levy JH, Zaidan JR, Faraj B (1986) Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetics. Anesth Analg 65: 739 742
7. Horrow JC (1985) Protamine: a review of its toxicity. Anesth Analg 64: 348 361
8. Hobbhahn J, Coputnzen PF, Habazettl H (1991) Heparin reversal by protamine in humans: complement, prostaglandins, blood cells, and hemodynamics. J Appl Physiol 71: 1415 1421
9. Schulte-Sasse U, Hess W, Tarnovv L (1982) Pulmonary vascular response to nitrous oxide in patients with normal and high pulmonary vascular resistance Anesthesiology 57: 9-13
10. White Pf, Way WL, Trevor AJ (19X2) Ketamine-its pharmacology and therapeutic uses. Anesthesiology 56: 119-136
11. Steward WJ, McSweeney SM, Kellett MA, Faxon DP, Ryan TJ (1984) Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation 70: 788-792
12. Horiguchi T, Enzan K, Mitsuhata H, Murata M, Suzuki M (1995) Heparin protamine complexes cause pulmonary hypertension in goats. Anesthesiology 83: 786-791
13. Hakim TS, Picone A, Oleary CE, Camporesi EM (1995) Protamine induced pulmonary venoconstriction in heparinized pigs. Anesth Analg (1995) 81: 38-43
14. Levy JH (1993) Antibody formation after drug administration during cardiac surgery: parameter for aprotinin use. J Heart Lung Transplant 12: S26 S33
15. Hermiller JB, Bambach D, Thompson MJ, Huss P, Fontana ME, Magorien RD, Unverferth DV, Leier CV (1982) Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Intern Med 97: 480-489